Viral hepatitis
130 results
1 - 100
Viral hepatitis 
Bile acids for viral hepatitis- Glucocorticosteroids for viral hepatitis C
- Interferon for acute hepatitis C
- Vaccines in alphabetical order
- Fever in a returning traveller
- A patient with jaundice (icterus)
- Cirrhosis of the liver
- Phyllanthus species for chronic hepatitis B virus infection: Cochrane systematic review
- Monitoring a child of a substance-abusing mother
- Sexually transmitted infections
- Vaccines for prophylaxis of viral infections in patients with hematological malignancies: Cochrane systematic review
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
- Colchicine for alcoholic and non‐alcoholic liver fibrosis and cirrhosis
- Immunoglobulins for preventing hepatitis A: Cochrane systematic review
- Autoimmune hepatitis
- Medicinal herbs for hepatitis C virus infection
- Ribavirin monotherapy for chronic hepatitis C
- Labour and delivery
- Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow‐responder adult patients
- Assessing a patient with an abnormal liver function test result
- Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission
- Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
- Elevated ESR (hypersedimentation)
- Vasculitides
- Ribavirin plus interferon versus interferon for chronic hepatitis C
- Erythema nodosum
- Xiao Chai Hu Tang, a herbal medicine, for chronic hepatitis B
- Entecavir for children and adults with chronic hepatitis B
- Chinese medicinal herbs for chronic hepatitis B
- Providing care for an alcohol or drug abuser
- Vaccinations
- Treatment of drug addicts
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus
- Bicyclol for chronic hepatitis C
- Occupational exposure to blood and body secretions
- Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma: Cochrane systematic review
- Bicyclol for chronic hepatitis B
- Alcoholic liver disease (ALD)
- Fatigue
- Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
- Traveller's infection prophylaxis
- Raynaud's phenomenon (RP) or white finger disease
- Bite wounds
- Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection
- Liver fibrosis stage based on the four factors (FIB‐4) score or Forns index in adults with chronic hepatitis C
- Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation: Cochrane systematic review
- Prolonged fever in the adult
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Interferon for interferon naive patients with chronic hepatitis C: Cochrane systematic review
- Gianotti-Crosti syndrome on the cheeks of a child - Image
- Pharmacological interventions for acute hepatitis B infection
- Hepatitis B immunoglobulin during pregnancy for prevention of mother‐to‐child transmission of hepatitis B virus
- Aminoadamantanes versus other antiviral drugs for chronic hepatitis C
- Treatment for hepatitis C virus‐associated mixed cryoglobulinaemia
- Pharmacological interventions for alcoholic liver disease (alcohol‐related liver disease)
- Pharmacological interventions for acute hepatitis C infection
- Interferon alpha for chronic hepatitis D
Boceprevir improves SVR in genotype 1 HCV (SPRINT-2)- Antenatal clinics and specialist care: consultations, referrals, treatment guidelines
- Aminoadamantanes for chronic hepatitis C
- Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C
- Acute diarrhoeal disease in a traveller
- Hepatic late adverse effects after antineoplastic treatment for childhood cancer
- Exanthem (eruptive skin rash)
- Antioxidant supplements for liver diseases
- Updated ACR guideline on managing patients with rheumatoid arthritis
- Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV‐infected, treatment‐naive adults